AGR, LMR and SIRI are the optimal combinations for risk stratification in advanced patients with non-small cell lung cancer following immune checkpoint blockers
Yun Zhou, Xia Liu, Biwen Wu, Biwen Wu, Biwen Wu, Cunte Chen, Yong Wu, Guolong Liu, Peipei Wang, Guolong Liu, Peipei Wang
Topics & Concepts
Risk stratificationMedicineOncologyLung cancerStratification (seeds)Immune systemInternal medicineImmune checkpointCancerIntensive care medicineImmunotherapyImmunologyBiologyGerminationSeed dormancyBotanyDormancyInflammatory Biomarkers in Disease PrognosisCancer Immunotherapy and BiomarkersCancer, Stress, Anesthesia, and Immune Response